Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride
Product Images NDC 21695-820
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 21695-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (E4020ca3 82d0 4668 B4bc 92e4a53c1f4e 02)
Fexofenadine HCl/pseudoephenadrine 60/120mg (E4020ca3 82d0 4668 B4bc 92e4a53c1f4e 03)
This is a product description for Fexofenadine HCI/Pseudoephedrine HCl ER Tablets, which are two-layer tablets containing 60mg of Fexofenadine HCI and 120mg of Pseudoephedrine HCI, made by Winthrop U.S., a business of sanofi-aventis U.S. LLC. The tablets are engraved with "WO7" on the white layer and have a clear film coating. These tablets are intended to be stored at controlled room temperature and kept out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.